GLP-1 (glucagon-like peptide 1) medications are used to primarily treat type 2 diabetes but have been widely used to aid in weight loss along with diet and exercise
Shows potential for stress reduction and mood support through HPA axis modulation
These symptoms can easily be mistaken for side effects of the GLP-1 medication itself, leading to mismanagement
Commenters stated that using Medicare data on fee-for-service case counts to develop a single weighted average standardized median MAO payer-specific negotiated rate by MS-DRG across hospitals means that data from hospitals with less MA penetration, which have less at stake in MA negotiations, is weighted more heavily than data from hospitals with high MA penetration that have more at stake
Rand EED, Smit S, Beukes M, Apostolides Z, Pirk CWW, Nicolson SW
Drug Metabolism and Disposition, 2025: 100081